Literature DB >> 14739487

Practical markers used in the diagnosis of neuroendocrine tumors.

Ricardo V Lloyd1.   

Abstract

Although there are many broad-spectrum neuroendocrine markers, chromogranin and synaptophysin are the principal ones used in diagnostic pathology. Other broad-spectrum neuroendocrine markers, transcription factors, and specific peptide markers used in the diagnosis of neuroendocrine tumors are reviewed. The use of different keratins in the differential diagnosis of endocrine tumors is also presented. The importance of using low-molecular-weight keratins such as CAM5.2 to avoid false-negative results in the workup of some neuroendocrine tumors is emphasized. Finally, the use of in situ hybridization in diagnostic pathology is briefly summarized.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14739487     DOI: 10.1385/ep:14:4:293

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  53 in total

1.  rab3 is a small GTP-binding protein exclusively localized to synaptic vesicles.

Authors:  G Fischer von Mollard; G A Mignery; M Baumert; M S Perin; T J Hanson; P M Burger; R Jahn; T C Südhof
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

Review 2.  Synaptophysin and chromogranins/secretogranins--widespread constituents of distinct types of neuroendocrine vesicles and new tools in tumor diagnosis.

Authors:  B Wiedenmann; W B Huttner
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1989

3.  Anti-lymphocyte antibody Leu-7 (HNK-1) recognizes a constituent of neuroendocrine granule matrix.

Authors:  A S Tischler; H Mobtaker; K Mann; G Nunnemacher; W J Jason; Y Dayal; R A Delellis; L Adelman; H J Wolfe
Journal:  J Histochem Cytochem       Date:  1986-09       Impact factor: 2.479

4.  Neural cell adhesion molecule: structure, immunoglobulin-like domains, cell surface modulation, and alternative RNA splicing.

Authors:  B A Cunningham; J J Hemperly; B A Murray; E A Prediger; R Brackenbury; G M Edelman
Journal:  Science       Date:  1987-05-15       Impact factor: 47.728

Review 5.  The polypeptide hormone-producing neuroendocrine cells and their tumors: an immunohistochemical analysis.

Authors:  R A DeLellis; H J Wolfe
Journal:  Methods Achiev Exp Pathol       Date:  1981

6.  New techniques in gene product analysis.

Authors:  R A DeLellis; H J Wolfe
Journal:  Arch Pathol Lab Med       Date:  1987-07       Impact factor: 5.534

7.  Peptidylglycine alpha-amidating monooxygenase (PAM) immunoreactivity and messenger RNA in human pituitary and increased expression in pituitary tumours.

Authors:  J H Steel; A Martínez; D R Springall; A M Treston; F Cuttitta; J M Polak
Journal:  Cell Tissue Res       Date:  1994-04       Impact factor: 5.249

8.  SNAP-25 is present in a SNARE complex in adrenal chromaffin cells.

Authors:  D Roth; R D Burgoyne
Journal:  FEBS Lett       Date:  1994-09-05       Impact factor: 4.124

9.  Immunocytochemical localization of peptidylglycine alpha-amidating monooxygenase enzymes (PAM) in human endocrine pancreas.

Authors:  A Martínez; L M Montuenga; D R Springall; A Treston; F Cuttitta; J M Polak
Journal:  J Histochem Cytochem       Date:  1993-03       Impact factor: 2.479

10.  SNAP-25 is expressed in islets of Langerhans and is involved in insulin release.

Authors:  K Sadoul; J Lang; C Montecucco; U Weller; R Regazzi; S Catsicas; C B Wollheim; P A Halban
Journal:  J Cell Biol       Date:  1995-03       Impact factor: 10.539

View more
  23 in total

1.  [Fulminant duodenal bleeding as first manifestation of a neuroendocrine carcinoma of the pancreatic head].

Authors:  Kerstin Schütte; Jan Bornschein; Doerthe Kuester; Gero Wieners; Peter Malfertheiner
Journal:  Med Klin (Munich)       Date:  2010-04

Review 2.  Neuroendocrine differentiation: The mysterious fellow of colorectal cancer.

Authors:  Britta Kleist; Micaela Poetsch
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

3.  Composite hemangioendothelioma with neuroendocrine marker expression: an aggressive variant.

Authors:  Kyle D Perry; Alyaa Al-Lbraheemi; Brian P Rubin; Jin Jen; Hongzheng Ren; Jin Sung Jang; Asha Nair; Jaime Davila; Stefan Pambuccian; Andrew Horvai; William Sukov; Henry D Tazelaar; Andrew L Folpe
Journal:  Mod Pathol       Date:  2017-07-21       Impact factor: 7.842

4.  [Neuroendocrine tumors].

Authors:  W Saeger
Journal:  Pathologe       Date:  2015-05       Impact factor: 1.011

5.  The Clinical Significance of Neuroendocrine Features in Invasive Breast Carcinomas.

Authors:  Billy Shui-Wun Lai; Julia Y Tsang; Ivan K Poon; Yan Shao; Siu-Ki Chan; Fiona K Tam; Sai-Yin Cheung; Ka-Ho Shea; Gary M Tse
Journal:  Oncologist       Date:  2020-06-16

6.  Aberrant intermediate filament and synaptophysin expression is a frequent event in malignant melanoma: an immunohistochemical study of 73 cases.

Authors:  Ryan C Romano; Jodi M Carter; Andrew L Folpe
Journal:  Mod Pathol       Date:  2015-05-29       Impact factor: 7.842

Review 7.  Cutaneous metastases as an initial manifestation of visceral well-differentiated neuroendocrine tumor: a report of four cases and a review of literature.

Authors:  Jaroslaw Jedrych; Klaus Busam; David S Klimstra; Melissa Pulitzer
Journal:  J Cutan Pathol       Date:  2013-12-03       Impact factor: 1.587

Review 8.  Radiology of the neuroendocrine neoplasms of the gastrointestinal tract: a comprehensive review.

Authors:  Sundeep Malla; Pawan Kumar; Kumble Seetharama Madhusudhan
Journal:  Abdom Radiol (NY)       Date:  2020-09-22

9.  Kaposi's Sarcoma-Associated Herpesvirus Infection Induces the Expression of Neuroendocrine Genes in Endothelial Cells.

Authors:  Mohanan Valiya Veettil; Gayathri Krishna; Arunava Roy; Anandita Ghosh; Dipanjan Dutta; Binod Kumar; Sayan Chakraborty; Thoppil Raveendran Anju; Neelam Sharma-Walia; Bala Chandran
Journal:  J Virol       Date:  2020-03-31       Impact factor: 5.103

Review 10.  Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors.

Authors:  Günter Klöppel; Guido Rindi; Martin Anlauf; Aurel Perren; Paul Komminoth
Journal:  Virchows Arch       Date:  2007-08-08       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.